SKULL BASE SURGERY/VOLUME 8, NUMBER model with a combination of SSS ligation and the injection of a thrombogenic material, kaolin-cephalin suspension (a reagent available for the partial thromboplastin time reaction), is currently the most established experimental model, which permits the observation of a true thrombotic process, not mechanical. Recent literature on experimental SSST well documented that (1) SSST causes brian damage when draining cortical veins are involved, not the SSS alone,' 2,4-6 that (2) increase of cerebral blood volume (CBV) and cerebral edema by venous flow obstruction results in intracranial hypertension and decreases regional cerebral blood flow (rCBF),2A46 and that (3) CBF monitoring could be useful for predicting brain damage subsequent to SVT and cortical vein occlusion. 4, 7, 8 We examined the pathophysiology of SSST from a clinical and experimental point of view. To do so, we investigated the prognostic factors from 19 patients with SSST and the mechanism responsible for brain damage following SSST using the rat SSST model. In addition, we had hoped to determine helpful monitors for early detection of critical conditions after SSST.
CLINICAL STUDY
Over the last 7 years, we treated 19 cases with SSST who were diagnosed by computed tomography (CT) scan, magnetic resonance image (MRI), and angiography.
The patients ranged in age from fifteen to sixty-four years (mean 39.4 years old). There were nine male and ten female. The location included six anterior, five middle, eight posterior third of SSS. The onset was sudden in nine and gradual in ten cases. The symptoms were headache in 14, convulsion in 12, motor weakness in 16, coma in seven, and focal deficit in five cases, respectively. The etiology included oral contraceptives in two, pregnancy in one, head injury in one, and unknown in 170 14. Eleven patients had good prognosis, 3 fair, and 1 bad.
Our treatment regimen includes urokinase therapy (480,000 units/day for 7 days) and administration of heparin (initial intravenous administration of 2,000 units and 20,000 units/days for 2 days) for cases without cerebral hemorrhage. Moreover, treatment for cerebral edema was performed with steroid and hypertonic diuretics.
Illustrative Cases
A 28-year-old woman (Case 1) had a headache and fever, and was brought to our hospital due to generalized convulsion. In the hospital emergency room, the consulting neurosurgeon found the left hemiparesis. Emergent CT showed low density areas in the right frontocentral and left frontal regions (Fig. 1A) , and angiography revealed the occlusion of middle 1/3 in SSS (Fig. iB) . Under the diagnosis of SSST, we treated the patients with heparin and urokinase. Also, steroid therapy was applied. The patient improved dramatically the next day. She had no deficit, and had since returned to her job.
A 53-year-old woman (Case 18) was brought to our hospital due to unconsciousness. She was in a coma stage, and had the right hemiparesis. CT showed diffuse brain edema and engorgement of cerebral veins ( Fig.  2A) , and angiography revealed the occlusion of all SSS (Fig. 2B) 
Materials and Methods
In twenty-three male Wistar rats (b.w. 320 ± 20.6gm), anesthesia was done by intraperitoneal injection of chloral hydrate (36mg/lOOg b.w.). Spontaneous ventilation was maintained, and rectal temperature was controlled at 37°C. Polyethylene catheters were inserted into the tail artery and the right femoral vein under an operating microscope (OP-microscope; Zeiss, Wetzlar, Germany). The arterial line served for continuous registration of arterial blood pressure and gas (PaO2, PaCO2, and arterial pH). After a 2.0 cm midline skin incision, a cranial window (9 mm X 6 mm) was made. The dura was left intact, and the SSS and bilateral parasagittal cortex (the right side dominant) were exposed. Then, fluorescence angiography was was carried out before, 30 minutes after, and 90 minutes after induction of SVT. of first choice for SVT, even in patients with intracranial bleedings, based on their experience of 115 treated patients with SVT for 15 years. Our clinical study suggested that the therapeutic regimen including heparin and urokinase was effective for patients with SSST when diagnosed early. Therefore, we can recommend this combination therapy of heparin and urokinase in cases without intracerebral hemorrhage. However, a delayed start of treatment and the abrupt development of the disease still lead to a poor outcome. Thus, we examined the pathological process of critical SSST using the experimental model. 8 We found that only the cases with the extension of thrombus from the SSS to the cortical veins after induction of SVT, which is confirmed by repeated fluorescence angiographies, had brain damage, and the trigger of these pathological processes was surely the extension of the thrombus. In these cases, tissue Hb Sao2 as well as rCBF decreased after the induction of SVT. Moreover, the reduction of tissue Hb Sao2 preceded the flow decrease due to the detection of desaturated blood from collateral pathway. Our data suggested the early influence on oxygen transport by SSST, resulting in the ischemia rapidly or almost simultaneously. With time after SSST, reduction of CBF together with tissue Hb Sao2 developed into below the ischemic threshold. Therefore, we concluded that CBF, tissue Hb Sao2, and repeated angiography can be helpful monitors for the early detection of critical conditions after SSST, and restraint on the ongoing thrombus is essential to protect the brain with SSST. Taken together, blood pressure of animals without brain damage was approximately 15% higher than that of sham-operated and animals with brain damage. This phenomenon attributes to maintaining cerebral perfusion pressure (CPP). The brain just at a critical level is considered to be sensitive to small change of CPP. This information must be important for the patient care with SSST. Therefore, CPP should be monitored carefully, and any reduction should be treated in patients. However, the mechanism of this phenomenon still remains uncertain, and must to evaluate it for future treatment alternatives. Finally, the thrombus in this experimental model extends progressively, not occluded at once, to the cortical veins, which is similar to the human SSST. Therefore, this model is suitable for the study of the treatment for SVT.
As to the radiological diagnosis for SVT, some authors suggested that MRI can replace angiography." '12 With the advancement of the diagnostic tool, SVT could be diagnosed earlier than before. On the other side, other author mentioned the difficulties of MRI-based diagnosis of dural sinus thrombosis. The use of MRI and magnetic resonance angiography in the diagnosis of SVT demands knowledge of the different stages and pitfalls, and intraarterial angiography is still required for certain diagnoses.'3 The patients should be evaluated by angiography as early as possible under the suspicion of SVT.
Recent studies on activated protein C resistance (APC-R) associated with venous thromboembolism rekindled the interest in cerebral venous thrombosis. APC-R is a common inhererited risk factor for venous thrombosis, which is due to a mutation in coagulation factor V (factor V Leiden mutation). According to these reports, this point mutation was found in 20% of patients with cerebral venous thrombosis compared with 2.7% control subjects. '4-'7 In conclusion, a brain with acute extension of thrombus from SSS to cortical veins becomes critical after SSST. The monitors of CBF, tissue Hb Sao2, and repeated angiography can detect early change after SSST. Also, the current study showed that the maintenance of CPP is quite important in this pathological condition. Regarding the therapy, the combination therapy of heparin and urokinase is effective in cases without intracerebral hemorrhage.
REVIEWERS' COMMENTS
This paper by Nakase and colleagues is a very interesting evaluation of 19 patients with superior sagittal sinus thrombosis (SSST), showing even in this relatively small group the importance of gender, rapid onset and posterior location of thrombus, but surprisingly not finding that age and clinical presentation were not important prognostic factors. The authors extended these interesting observations by developing an experimental model of gradual thrombosis of the SSST in rats. In this model, occlusion is gradual over several days, and in some of the animals goes on to involve cortical veins as well as the SSST. In fact, the animals remained relatively asymptomatic unless the cortical veins were involved. Why some animals developed cortical vein involvement and others did not is not clear. Whether or not activated protein kinase plays a role in the rat models as it may do in human disease is not specifically addressed by the authors.
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The authors provide an interesting study on the treatment of superior sagittal sinus thrombosis. They made a clinical study with 19 cases and created an experimental model. They conclude that the use of heparin and urokinase in the treatment of sagittal sinus thrombosis is strongly recommended in the management of these patients. The treatment of sagittal sinus thrombosis is controversial and until now there are no large series that support the therapy with heparin and urokinase. We think that a multicentric study should be necessary to demonstrate the benefits of such a therapy. In the mean time the medical treatment will mostly be limited to the use of corticosteroids, mannitol and anticonvulsivants.
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